TBIO

Translate Bio Inc.

Price

$0.001000

return (12m)

-95.45%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

TBIO price

Translate Bio

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.09%

3 months

0.00%

1 year

-95.45%

2 years

-99.97%

5 years

-100.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals TBIO

Valuation

P/E

0.00

Sector -5.97

Industry -5.97

P/BV

0.00

Sector 1.71

Industry 1.71

P/Revenue (PSR)

0.00

Sector -4.85

Industry -4.85

EV/EBITDA

0.47

Sector -34,753,237.72

Industry -34,753,237.72

EV/EBIT

0.43

Sector -36,548,779.28

Industry -36,548,779.28

P/EBITDA

0.00

Sector -6.10

Industry -6.10

P/EBIT

0.00

Sector -6.68

Industry -6.68

P/Total Assets

0.00

Sector 1.38

Industry 1.38

P/Net Current Assets

0.00

Sector -9,675,323.50

Industry -9,675,323.50

P/Working Capital

0.00

Sector -1,571,014.60

Industry -1,571,014.60

EPS

-24.78

Sector -2.62

Industry -2.62

BVPS

4.98

Sector 1.51

Industry 1.51

Efficiency

Gross Margin

47.92%

Sector 35.44%

Industry 35.44%

EBITDA Margin

-680.00%

Sector -16,590.01%

Industry -16,590.01%

EBIT Margin

-732.26%

Sector -4,202,867.70%

Industry -4,202,867.70%

Operating Margin

-100.00%

Sector -44.29%

Industry -44.29%

Net Profit Margins

-100.00%

Sector -45.76%

Industry -45.76%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-497.99%

Sector -85.46%

Industry -85.46%

ROA

-93.97%

Sector -77.38%

Industry -77.38%

ROIC

-100.49%

Sector -1,826.60%

Industry -1,826.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.89

Sector 2.92

Industry 2.92

Net Debt / EBITDA

0.47

Sector -13,812,189.96

Industry -13,812,189.96

Net Debt / EBIT

0.43

Sector -3.00

Industry -3.00

Net Debt / Equity

-0.50

Sector -1.09

Industry -1.09

Gross Debt / Equity

0.53

Sector 0.00

Industry 0.00

Equity/Assets

0.19

Sector 0.32

Industry 0.32

Liabilities/Assets

0.81

Sector 0.36

Industry 0.36

Growth

5Y Revenue CAGR

9.67%

Sector -

Industry -

5Y Earnings CAGR

4.93%

Sector -

Industry -

Fundamentals TBIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TBIO Translate Bio Inc.	$0.00	-95.45%	0.00%	0.00	0.00	-497.99%	-100.00%
JNJ Johnson & Johnson	$271.49	56.42%	1.94%	30.90	7.65	24.76%	21.48%
PFE Pfizer Inc.	$28.17	20.86%	6.21%	36.42	1.85	5.07%	6.80%
ABBV AbbVie Inc.	$265.73	31.11%	2.57%	74.50	-79.29	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.01	-9.99%	4.00%	11.35	6.03	53.11%	35.32%
MRK Merck & Co. Inc.	$152.83	87.69%	2.21%	118.22	8.93	7.56%	4.77%
AZN AstraZeneca PLC	$166.39	5.92%	1.94%	24.54	5.09	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.32	46.11%	3.73%	14.81	6.16	41.59%	18.87%
ZTS Zoetis Inc.	$77.94	-49.16%	2.64%	12.45	10.35	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$843.29	41.75%	0.43%	20.07	2.74	13.65%	27.86%
AMGN Amgen Inc.	$438.74	53.36%	2.25%	26.93	20.15	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$108.27	52.21%	0.00%	30.63	88.25	288.14%	24.86%
MCK McKesson Corporation	$863.36	23.45%	0.38%	22.35	-78.88	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$550.39	39.57%	0.00%	31.74	6.90	21.76%	35.00%
CAH Cardinal Health Inc.	$229.56	52.00%	0.89%	31.14	-19.59	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$38.45	4.97%	0.00%	12.30	2.23	18.14%	18.89%
BIIB Biogen Inc.	$218.15	56.95%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TBIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Translate Bio

Translate Bio Inc.

Average Investor10 user rating

4.0 (2 people)

United States

10 years

Founded: 2016

2018

Time since IPO - 8 years

122

Employees

Translate Bio Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.00 Thousand, with shareholders equity totaling $9.95 million.

The company employs approximately 122 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Translate Bio Inc. reported $17.53 million in revenue, generating net income of $-49.55 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TBIO.

Market cap

$2.00 Thousand

Net worth

$9.95 million

$9,950,000.00

Assets

$52.73 million

$52,730,000.00

Total Shares Outstanding

2.00 million

2,000,000

Average Daily Trading Volume

$138.68

Sector

Health Care

Industry

Biotechnology

TBIO

TBIO revenue and profits

Financial Results TBIO

DRAG THE FRAME TO SEE MORE DATA

TBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$863.36 25,73% (12M)

P/E

22.35

0.38%

ROE

-352.96%

P/BV

-78.88

CAH - Cardinal Health

$229.56 56,63% (12M)

P/E

31.14

0.89%

ROE

-62.92%

P/BV

-19.59

JNJ - Johnson & Johnson

$271.49 55,22% (12M)

P/E

30.90

1.94%

ROE

24.76%

P/BV

7.65

ABBV - AbbVie

$265.73 30,20% (12M)

P/E

74.50

2.57%

ROE

-106.44%

P/BV

-79.29

MRK - Merck & Co.

$152.83 80,72% (12M)

P/E

118.22

2.21%

ROE

7.56%

P/BV

8.93

AZN - AstraZeneca

$166.39 6,27% (12M)

P/E

24.54

1.94%

ROE

20.74%

P/BV

5.09

PFE - Pfizer

$28.17 16,49% (12M)

P/E

36.42

6.21%

ROE

5.07%

P/BV

1.85

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$863.36 25,73% (12 M)

P/L

22.35

0.38%

ROE

-352.96%

P/VP

-78.88

CAH - Cardinal Health

$229.56 56,63% (12 M)

P/L

31.14

0.89%

ROE

-62.92%

P/VP

-19.59

JNJ - Johnson & Johnson

$271.49 55,22% (12 M)

P/L

30.90

1.94%

ROE

24.76%

P/VP

7.65

ABBV - AbbVie

$265.73 30,20% (12 M)

P/L

74.50

2.57%

ROE

-106.44%

P/VP

-79.29

MRK - Merck & Co.

$152.83 80,72% (12 M)

P/L

118.22

2.21%

ROE

7.56%

P/VP

8.93

AZN - AstraZeneca

$166.39 6,27% (12 M)

P/L

24.54

1.94%

ROE

20.74%

P/VP

5.09

PFE - Pfizer

$28.17 16,49% (12 M)

P/L

36.42

6.21%

ROE

5.07%

P/VP

1.85

Frequently Asked Questions

What is the price of Translate Bio (TBIO) today?

A cotação de Translate Bio (TBIO) hoje está em US$ 0.001000, com uma variação de -95.45% em relação ao último ano. A cotação de Translate Bio (TBIO) iniciou o ano negociando na casa dos US$ 0.05 e hoje está em US$ 0.001000. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Translate Bio (TBIO) e dados de ações do Ibovespa e mercados internacionais.

Quando Translate Bio (TBIO) paga dividendos?

Translate Bio (TBIO) não distribuiu dividendos no último ano.

Is Translate Bio (TBIO) a good investment?

Atualmente, Translate Bio (TBIO) está cotada a US$ 0.001000, com um P/L de 0.00, representando um desvio de -935% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -95.45 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -95.45%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Translate Bio (TBIO) stock?

Investir em ações de Translate Bio (TBIO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Translate Bio (TBIO) yield today?

A rentabilidade de Translate Bio (TBIO) foi de -9.09% no último mês, -95.45% no último ano e -100.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Translate Bio (TBIO) hoje, o investimento total seria de US$ 0.10, com base na cotação atual de US$ 0.001000.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.004550
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.10

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TBIO

Translate Bio Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TBIO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING TBIO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Translate Bio

Translate Bio Inc.

United States

10 years

2018

122

PROFIT X PRICE TBIO

Financial Results TBIO

TBIO cash flow

Asset, Revenue and Profit Growth - TBIO

TBIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions